Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study

References

• Alanazi AM, Abdel-Aziz AA-M, Shawer TZ, et al. Synthesis, antitumor and antimicrobial activity of some new 6-methyl-3-phenyl-4(3H)-quinazolinone analogues: in silico studies. J Enzyme Inhib Med Chem 2016;31:721–35.
   PubMed Web of Science ®Google Scholar
• Mohamed MA, Ayyad RR, Shawer TZ, et al. Synthesis and antitumor evaluation of trimethoxyanilides based on 4(3H)-quinazolinone scaffolds. Eur J Med Chem 2016;112:106–13.
   PubMed Web of Science ®Google Scholar
• Abdel-Aziz AA-M, El-Azab AS, El-Subbagh HI, et al. Design, synthesis, single-crystal and preliminary antitumor activity of novel arenesulfonylimidazolidin-2-ones. Bioorg Med Chem Lett 2012;22:2008–14.
   PubMed Web of Science ®Google Scholar
• Avendańo C, Menéndez J. Medicinal chemistry of anticancer agents. Amsterdam: Elsevier; 2008.
   Google Scholar
• Varmus H. The new era in cancer research. Science 2006;312:1162–5.
   PubMed Web of Science ®Google Scholar
• Eckhardt S. Recent progress in the development of anticancer agents. Curr Med Chem Anticancer Agents 2002;2:419–39.
   PubMedGoogle Scholar
• (a) Abdel-Aziz AA-M, El-Azab AS, Alanazi AM, et al. Synthesis and potential antitumor activity of 7-(4-substituted piperazin-1-yl)-4-oxoquinolines based on ciprofloxacin and norfloxacin scaffolds: in silico studies. J Enzyme Inhib Med Chem 2016;31:796–809. (b) Abdel-Aziz AA-M, El-Azab AS, Alanazi AM, et al. Design, synthesis and antibacterial activity of fluoroquinolones containing bulky arenesulfonyl fragment: 2D-QSAR and docking study. Eur J Med Chem 2011;46:5487–97.
   PubMed Web of Science ®Google Scholar
• El-Azab AS, Al-Omar MA, Abdel-Aziz AA-M, et al. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study. Eur J Med Chem 2010;45:4188–98.
   PubMed Web of Science ®Google Scholar
• Al-Suwaidan IA, Abdel-Aziz AA-M, Shawer TZ, et al. Synthesis, antitumor activity and molecular docking study of some novel 3-benzyl-4 (3H) quinazolinone analogues. J Enzyme Inhib Med Chem 2016;31:78–89.
   PubMed Web of Science ®Google Scholar
• Al-Obaid A, Abdel-Hamide S, El-Kashef H, et al. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4 (3H)-quinazolinone analogs. Eur J Med Chem 2009;44:2379–91.
   PubMed Web of Science ®Google Scholar
• Alanazi AM, Al-Suwaidan IA, Abdel-Aziz AA-M, et al. Design, synthesis and biological evaluation of some novel substituted 2-mercapto-3-phenethylquinazolines as antitumor agents. Med Chem Res 2013;22:5566–77.
   Web of Science ®Google Scholar
• Al-Suwaidan IA, Alanazi AM, Abdel-Aziz AA-M, et al. Design, synthesis and biological evaluation of 2-mercapto-3-phenethylquinazoline bearing anilide fragments as potential antitumor agents: molecular docking study. Bioorg Med Chem Lett 2013;23:3935–41.
   PubMed Web of Science ®Google Scholar
• Alanazi AM, Abdel-Aziz AA-M, Al-Suwaidan IA, et al. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents. Eur J Med Chem 2014;79:446–54.
   PubMed Web of Science ®Google Scholar
• Bazley LA, Gullick WJ. The epidermal growth factor receptor family. Endocr Relat Cancer 2005;12(Suppl 1):S17–S27.
   PubMed Web of Science ®Google Scholar
• Hirsch FR, Varella-Garcia M, Bunn PA Jr, et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 2003;21:3798–807.
   PubMed Web of Science ®Google Scholar
• Bishayee S. Role of conformational alteration in the epidermal growth factor receptor (EGFR) function. Biochem Pharmacol 2000;60:1217–23.
   PubMed Web of Science ®Google Scholar
• Ogiso H, Ishitani R, Nureki O, et al. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 2002;110:775–87.
   PubMed Web of Science ®Google Scholar
• Umekita Y, Ohi Y, Sagara Y, Yoshida H. Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients. Int J Cancer 2000;89:484–7.
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhang H, Wang F. EGFR inhibition studies by hybrid scaffolds for their activity against ovarian cancer. J Buon 2016;21:1482–90.
   PubMed Web of Science ®Google Scholar
• Sheikh IA, Hassan HM. In silico identification of novel erlotinib analogues against epidermal growth factor receptor. Anticancer Res 2016;36:6125–32.
   PubMed Web of Science ®Google Scholar
• Mowafy S, Galanis A, Doctor ZM, et al. Toward discovery of mutant EGFR inhibitors; Design, synthesis and in vitro biological evaluation of potent 4-arylamino-6-ureido and thioureido-quinazoline derivatives. Bioorg Med Chem 2016;24:3501–12.
   PubMed Web of Science ®Google Scholar
• Sun M, Zhao J, Chen X, et al. Synthesis and biological evaluation of novel tricyclic oxazine and oxazepine fused quinazolines. Part 2: gefitinib analogs. Bioorg Med Chem Lett 2016;26:4842–5.
   PubMed Web of Science ®Google Scholar
• Minkovsky N, Berezov A. BIBW-2992, a dual receptor tyrosine kinase inhibitor for the treatment of solid tumors. Curr Opin Investig Drugs 2008;9:1336–46.
   PubMedGoogle Scholar
• Hirsh V. Afatinib (BIBW 2992) development in non-small-cell lung cancer. Future Oncol 2011;7:817–25.
   PubMed Web of Science ®Google Scholar
• Barlesi F, Tchouhadjian C, Doddoli C, et al. Gefitinib (ZD1839, Iressa) in non-small-cell lung cancer: a review of clinical trials from a daily practice perspective. Fundam Clin Pharmacol 2005;19:385–93.
   PubMed Web of Science ®Google Scholar
• Arteaga CL, Johnson DH. Tyrosine kinase inhibitors-ZD1839 (Iressa). Curr Opin Oncol 2001;13:491–8.
   PubMed Web of Science ®Google Scholar
• Barker AJ, Gibson KH, Grundy W, et al. Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer. Bioorg Med Chem Lett 2001;11:1911–14.
   PubMed Web of Science ®Google Scholar
• Ganjoo KN, Wakelee H. Review of erlotinib in the treatment of advanced non-small cell lung cancer. Biologics 2007;1:335–46.
   PubMedGoogle Scholar
• Stamos J, Sliwkowski MX, Eigenbrot C. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J Biol Chem 2002;277:46265–72.
   PubMed Web of Science ®Google Scholar
• Wissner A, Berger DM, Boschelli DH, et al. 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors. J Med Chem 2000;43:3244–56.
   PubMed Web of Science ®Google Scholar
• Minami Y, Shimamura T, Shah K, et al. The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272. Oncogene 2007;26:5023–7.
   PubMed Web of Science ®Google Scholar
• Wissner A, Mansour TS. The development of HKI-272 and related compounds for the treatment of cancer. Arch Pharm (Weinheim) 2008;341:465–77.
   PubMed Web of Science ®Google Scholar
• Rabindran SK, Discafani CM, Rosfjord EC, et al. Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase. Cancer Res 2004;64:3958–65.
   PubMed Web of Science ®Google Scholar
• Kiesel BF, Parise RA, Wong A, et al. LC-MS/MS assay for the quantitation of the tyrosine kinase inhibitor neratinib in human plasma. J Pharm Biomed Anal 2017;134:130–6.
   PubMed Web of Science ®Google Scholar
• Laheru D, Croghan G, Bukowski R, et al. A phase I study of EKB-569 in combination with capecitabine in patients with advanced colorectal cancer. Clin Cancer Res 2008;14:5602–9.
   PubMed Web of Science ®Google Scholar
• Luethi D, Durmus S, Schinkel AH, et al. Liquid chromatography-tandem mass spectrometry assay for the EGFR inhibitor pelitinib in plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2013;934:22–5.
   PubMed Web of Science ®Google Scholar
• Pisaneschi F, Nguyen QD, Shamsaei E, et al. Development of a new epidermal growth factor receptor positron emission tomography imaging agent based on the 3-cyanoquinoline core: synthesis and biological evaluation. Bioorg Med Chem 2010;18:6634–45.
   PubMed Web of Science ®Google Scholar
• Lu S, Zheng W, Ji L, et al. Synthesis, characterization, screening and docking analysis of 4-anilinoquinazoline derivatives as tyrosine kinase inhibitors. Eur J Med Chem 2013;61:84–94.
   PubMed Web of Science ®Google Scholar
• Pawar VG, Sos ML, Rode HB, et al. Synthesis and biological evaluation of 4-anilinoquinolines as potent inhibitors of epidermal growth factor receptor. J Med Chem 2010;53:2892–901.
   PubMed Web of Science ®Google Scholar
• Mrozek-Wilczkiewicz A, Spaczynska E, Malarz K, et al. Design, synthesis and in vitro activity of anticancer styrylquinolines. The p53 independent mechanism of action. PLoS One 2015;10:e0142678.
   PubMed Web of Science ®Google Scholar
• Chang FS, Chen W, Wang C, et al. Synthesis and antiproliferative evaluations of certain 2-phenylvinylquinoline (2-styrylquinoline) and 2-furanylvinylquinoline derivatives. Bioorg Med Chem 2010;18:124–33.
   PubMed Web of Science ®Google Scholar
• Musiol R, Jampilek J, Kralova K, et al. Investigating biological activity spectrum for novel quinoline analogues. Bioorg Med Chem 2007;15:1280–8.
   PubMed Web of Science ®Google Scholar
• Podeszwa B, Niedbala H, Polanski J, et al. Investigating the antiproliferative activity of quinoline-5,8-diones and styrylquinolinecarboxylic acids on tumor cell lines. Bioorg Med Chem Lett 2007;17:6138–41.
   PubMed Web of Science ®Google Scholar
• Jiang N, Zhai X, Li T, et al. Design, synthesis and antiproliferative activity of novel 2-substituted-4-amino-6-halogenquinolines. Molecules 2012;17:5870–81.
   PubMed Web of Science ®Google Scholar
• Vega-Avila E, Pugsley MK. An overview of colorimetric assay methods used to assess survival or proliferation of mammalian cells. Proc West Pharmacol Soc 2011;54:10–14.
   PubMedGoogle Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
   PubMed Web of Science ®Google Scholar
• Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271–7.
   PubMed Web of Science ®Google Scholar
• Mauceri HJ, Hanna NN, Beckett MA, et al. Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature 1998;394:287–91.
   PubMed Web of Science ®Google Scholar
• John H. Chinolinderivate, XXXVIII. Synthese 2-phenylierter-3-Oxy-chinolin-4-carbonsäuren. Adv Synth Catal 1932;133:259–72.
   Google Scholar
• Zhong L, Guo XN, Zhang XH, et al. Expression and purification of the catalytic domain of human vascular endothelial growth factor receptor 2 for inhibitor screening. Biochim Biophys Acta 2005;1722:254–61.
   PubMed Web of Science ®Google Scholar
• MOE. 2008.10 of Chemical Computing Group. Inc. Available from: http://www.chemcomp.com [last accessed 1 Sep 2017].
   Google Scholar
• (a) Al-Suwaidan IA, Alanazi AM, El-Azab AS, et al. Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2. Bioorg Med Chem Lett 2013;23:2601–5. (b) Goda FE, Abdel-Aziz AA-M, Ghoneim HA. Synthesis and biological evaluation of novel 6-nitro-5-substituted aminoquinolines as local anesthetic and anti-arrhythmic agents: molecular modeling study. Bioorg Med Chem 2005;13:3175–83.
   PubMed Web of Science ®Google Scholar
• Alanazi AM, El-Azab AS, Al-Suwaidan IA, et al. Structure-based design of phthalimide derivatives as potential cyclooxygenase-2 (COX-2) inhibitors: anti-inflammatory and analgesic activities. Eur J Med Chem 2015;92:115–23.
   PubMed Web of Science ®Google Scholar
• El-Gamal MI, Bayomi SM, El-Ashry SM, et al. Synthesis and anti-inflammatory activity of novel (substituted)benzylidene acetone oxime ether derivatives: molecular modeling study. Eur J Med Chem 2010;45:1403–14.
   PubMed Web of Science ®Google Scholar
• Gomes R, Diniz AM, Jesus A, et al. The synthesis and reaction network of 2-styryl-1-benzopyrylium salts: an unexploited class of potential colorants. Dyes Pigm 2009;81:69–79.
   Web of Science ®Google Scholar
• Sandmeyer T. Ueber Isonitrosoacetanilide und deren Kondensation zu Isatinen. Helv Chim Acta 1919;2:234–42.
   Google Scholar
• Massoud MA, El Bialy SA, Bayoumi WA, El Husseiny WM. Synthesis of new 2-and 3-hydroxyquinoline-4-carboxylic acid derivatives as potential antioxidants. Heterocycl Commun 2014;20:81–8.
   Web of Science ®Google Scholar
• Holla BS, Poojary KN, Poojary B, Bhat KS, et al. Synthesis, characterization and antibacterial activity studies on some fluorine containing quinoline-4-carboxylic acids and their derivatives. Indian J Chem 2005;44B:2114–19.
   Google Scholar